Enter inventor name

Mireille Sevrin

USPTO Granted Patents = 31 (Patent Applications = 1)

Average Co-Inventor Count = 4.2

ph-index = 6

Forward Citations = 131(Granted Patents)

Company Filing History:

Years Active: 1986-2012

Loading Chart...

31 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8258168 - 2H or 3H-benzo[E]indazol-1-YL carbamate derivatives, the preparation and therapeutic use thereof (2012-09-04),

2. 8114899 - 2H- or 3H-benzo[e]indazol-1-yl carbamate derivatives, the preparation and therapeutic use thereof (2012-02-14),

3. 7951821 - N-[phenyl(piperidin-2-yl)methyl]benzamide derivatives, preparation thereof, and use thereof in therapy (2011-05-31),

4. 7501449 - [object Object] (2009-03-10),

5. 7326722 - N-[Phenyl(piperidin-2-yl)methyl]benzamide derivatives, their preparation and their application in therapy (2008-02-05),

6. 7205319 - N-[phenyl (piperidin-2-yl) methyl]benzamide derivatives, preparation thereof, and use thereof in therapy (2007-04-17),

7. 6451795 - 4-oxo-3,5-dihydro-4H-pyridazino[4,5-b]indole-1-carboxamide derivatives, preparation and therapeutic use (2002-09-17),

8. 6395729 - Use of pyridazino[4,5-b]indole-1-acetamide derivatives for preparing medicines for treating diseases related to the dysfunction of peripheral benzodiazepin receptors (2002-05-28),

9. 6262045 - 4-Oxo-3,5-dihydro-4H-pyridazino[4,5-b]-indole-1-acetamide derivatives, their preparation and their application in therapy (2001-07-17),

10. 6221879 - 8-azabicyclo[3.2.1] octane-3-methanamine derivatives as ligands of D2 and D3 dopamine and 5HT1A and 5HT2 serotonin receptors (2001-04-24),

11. 6075021 - 1H-pyrido[3,4-b]indole-4-carboxamide derivatives, preparation and (2000-06-13),

12. 5929078 - 1-�2-(2,3-Dihydro-1H-inden-1-yl)ethyl!-4-(naphthalen-1-yl) piperazine, (1999-07-27),

13. 5922739 - 5-Naphthalen-1-yl-1,3-dioxane derivatives, preparation and therapeutical (1999-07-13),

14. 5665733 - 3-phenylisoquinol-1(2H)-one derivatives their preparation and their (1997-09-09),

15. 5614517 - 8-Oxo-5,8-dihydro-6H-dibenzo[a,g]quinolizine-13-propanoic acid (1997-03-25),

Certainly! Here is the article:

Title: The Inventive Journey of Mireille Sevrin in Paris

Introduction:

Mireille Sevrin is a prolific inventor based in the vibrant city of Paris, France. With a remarkable total of 31 patents to his name, Sevrin has made significant contributions to the field of pharmacology and drug development. His latest patents showcase his innovative spirit and commitment to advancing therapeutic solutions for various medical conditions.

Latest Patents:

Sevrin's most recent patents focus on 2H or 3H-benzo[E]indazol-1-YL carbamate derivatives. These compounds, defined by the formula (I) in the patent disclosures, offer unique therapeutic properties. The patents not only cover the preparation methods for these derivatives but also highlight their potential use in pharmaceutical compositions for effective treatment strategies.

Career Highlights:

Throughout his career, Sevrin has lent his expertise to esteemed pharmaceutical companies such as Synthelabo and Sanofi-Aventis. His tenure at these renowned organizations has been marked by groundbreaking research and the successful development of innovative medical solutions. Sevrin's dedication to pushing the boundaries of traditional pharmacology has earned him a reputation as a trailblazer in the industry.

Collaborations:

In his professional journey, Sevrin has been fortunate to collaborate with talented individuals who share his passion for innovation. Notable coworkers such as Pascal George and Jacques Froissant have contributed to the success of the projects Sevrin has been involved in. The synergy created by these collaborative efforts has led to the creation of patents that have the potential to revolutionize the field of drug development.

Conclusion:

In conclusion, Mireille Sevrin stands as a beacon of creativity and ingenuity in the realm of pharmaceutical inventions. His penchant for exploration and discovery has paved the way for transformative advancements in the field. With a rich portfolio of patents and a steadfast commitment to innovation, Sevrin continues to inspire and shape the landscape of modern pharmacology.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com